• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

降低肾细胞癌发病率的可改变风险因素:来自前列腺、肺癌、结直肠癌和卵巢癌(PLCO)试验的见解。

Modifiable risk factors to reduce renal cell carcinoma incidence: Insight from the PLCO trial.

作者信息

Gelfond Jonathan, Al-Bayati Osamah, Kabra Aashish, Iffrig Kevan, Kaushik Dharam, Liss Michael A

机构信息

Department of Biostatistics, University of Texas Health Science Center San Antonio, San Antonio, TX.

Department of Urology, University of Texas Health Science Center San Antonio, San Antonio, TX.

出版信息

Urol Oncol. 2018 Jul;36(7):340.e1-340.e6. doi: 10.1016/j.urolonc.2018.04.011. Epub 2018 May 17.

DOI:10.1016/j.urolonc.2018.04.011
PMID:29779672
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11697291/
Abstract

INTRODUCTION

Identify modifiable factors contributing to renal cell carcinoma in the PCLO to target disease prevention and reduce health care costs.

METHODS

The prostate, lung, colorectal, and ovarian database were queried for the primary outcome of kidney cancer. Demographics were investigated, specifically focusing on modifiable risk factors. Statistical analysis includes the Student t-test for continuous variables, chi-squared or Fisher's exact tests for dichotomous and categorical variables for bivariate analysis. The Cox proportional hazards model was used in a multivariate time-to-event analysis.

RESULTS

We investigate existing data relating specifically to renal cancer. After missing data were excluded, we analyzed 149,683 subjects enrolled in the prostate, lung, colorectal, and ovarian trial and noted 0.5% (n = 748) subjects developed renal cancer. Age, male gender, body mass index, diabetes, and hypertension were all significant associated with renal cancer in bivariate analysis (P<0.05). Men have a significant increased risk of kidney cancer over women (hazard ratio [HR] = 1.85; 95% CI: 1.58-2.16; P<0.0001). Nonmodifiable risk factors that are associated with kidney cancer include age (HR = 1.05; 95% CI: 1.01; 1.05, P = 0.001). Modifiable risk factors include obesity measured by body mass index (HR = 1.05; 95% CI: 1.02-1.07; P<0.0001), hypertension (HR = 1.32; 95% CI: 1.13-1.54; P = 0.0004), and smoking in pack-years (HR = 1.04; 95% CI: 1.02-1.07; P = 0.0002).

CONCLUSIONS

Obesity, hypertension, and smoking are the 3 modifiable risk factors that could aggressively be targeted to reduce renal cell carcinoma.

摘要

引言

确定导致PCLO中肾细胞癌的可改变因素,以针对疾病预防并降低医疗成本。

方法

查询前列腺、肺、结肠直肠和卵巢数据库中的肾癌主要结局。对人口统计学进行调查,特别关注可改变的风险因素。统计分析包括对连续变量进行Student t检验,对二元和分类变量进行卡方检验或Fisher精确检验以进行双变量分析。在多变量事件发生时间分析中使用Cox比例风险模型。

结果

我们研究了专门与肾癌相关的现有数据。排除缺失数据后,我们分析了149,683名参加前列腺、肺、结肠直肠和卵巢试验的受试者,发现0.5%(n = 748)的受试者患了肾癌。在双变量分析中,年龄、男性性别、体重指数、糖尿病和高血压均与肾癌显著相关(P<0.05)。男性患肾癌的风险显著高于女性(风险比[HR]=1.85;95%置信区间:1.58 - 2.16;P<0.0001)。与肾癌相关的不可改变风险因素包括年龄(HR = 1.05;

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a5a/11697291/5d53cd15001a/nihms-2042291-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a5a/11697291/9c00c1332cfd/nihms-2042291-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a5a/11697291/b13ce7494844/nihms-2042291-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a5a/11697291/5d53cd15001a/nihms-2042291-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a5a/11697291/9c00c1332cfd/nihms-2042291-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a5a/11697291/b13ce7494844/nihms-2042291-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a5a/11697291/5d53cd15001a/nihms-2042291-f0003.jpg

相似文献

1
Modifiable risk factors to reduce renal cell carcinoma incidence: Insight from the PLCO trial.降低肾细胞癌发病率的可改变风险因素:来自前列腺、肺癌、结直肠癌和卵巢癌(PLCO)试验的见解。
Urol Oncol. 2018 Jul;36(7):340.e1-340.e6. doi: 10.1016/j.urolonc.2018.04.011. Epub 2018 May 17.
2
Hormonal manipulation with finasteride or oral contraception does not influence incidence of renal cell carcinoma.使用非那雄胺或口服避孕药进行激素调控不会影响肾细胞癌的发病率。
Eur J Cancer Prev. 2018 Sep;27(5):449-452. doi: 10.1097/CEJ.0000000000000345.
3
Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial.基于前列腺、肺、结肠直肠和卵巢癌筛查试验以及国家肺癌筛查试验参与者的肾细胞癌风险估计。
Urol Oncol. 2016 Apr;34(4):167.e9-16. doi: 10.1016/j.urolonc.2015.10.011. Epub 2015 Nov 18.
4
Risk factors for renal cell carcinoma in the VITAL study.VITAL 研究中的肾癌风险因素。
J Urol. 2013 Nov;190(5):1657-61. doi: 10.1016/j.juro.2013.04.130. Epub 2013 May 9.
5
Obesity, hypertension, and the risk of kidney cancer in men.男性肥胖、高血压与肾癌风险
N Engl J Med. 2000 Nov 2;343(18):1305-11. doi: 10.1056/NEJM200011023431804.
6
Risk factors for renal cell cancer: the multiethnic cohort.肾细胞癌的危险因素:多民族队列研究
Am J Epidemiol. 2007 Oct 15;166(8):932-40. doi: 10.1093/aje/kwm170. Epub 2007 Jul 26.
7
Hypertension and risk of renal cell carcinoma among white and black Americans.白人和黑人美国人的高血压与肾细胞癌风险。
Epidemiology. 2011 Nov;22(6):797-804. doi: 10.1097/EDE.0b013e3182300720.
8
Cigarette smoking and renal cell carcinoma risk among black and white Americans: effect modification by hypertension and obesity.美国黑人和白人的吸烟与肾细胞癌风险:高血压和肥胖的作用修饰。
Cancer Epidemiol Biomarkers Prev. 2012 May;21(5):770-9. doi: 10.1158/1055-9965.EPI-11-1109. Epub 2012 Mar 16.
9
Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention.当代肾细胞癌的流行病学:初级预防的视角。
World J Urol. 2010 Jun;28(3):247-52. doi: 10.1007/s00345-010-0555-1.
10
Understanding racial disparities in renal cell carcinoma incidence: estimates of population attributable risk in two US populations.了解肾细胞癌发病率的种族差异:两个美国人群中人群归因风险的估计。
Cancer Causes Control. 2020 Jan;31(1):85-93. doi: 10.1007/s10552-019-01248-1. Epub 2019 Nov 28.

引用本文的文献

1
The disease burden of kidney cancer in Asian countries and regions from 1990 to 2021: a study based on the Global Burden of Disease database.1990年至2021年亚洲国家和地区肾癌的疾病负担:一项基于全球疾病负担数据库的研究。
Transl Androl Urol. 2025 Apr 30;14(4):1049-1065. doi: 10.21037/tau-2024-652. Epub 2025 Apr 27.
2
The causal effect of serum micronutrients on malignant kidney neoplasm in European descent.血清微量营养素对欧洲血统人群恶性肾肿瘤的因果效应。
Front Oncol. 2023 Aug 16;13:1191825. doi: 10.3389/fonc.2023.1191825. eCollection 2023.
3
Sex Differences in Renal Cell Carcinoma: The Importance of Body Composition.**译文**:肾细胞癌的性别差异:身体成分的重要性。
Ann Surg Oncol. 2023 Feb;30(2):1269-1276. doi: 10.1245/s10434-022-12738-z. Epub 2022 Nov 9.
4
Association Between Diabetes and the Risk of Kidney Cancer: Systematic Review and Meta-Analysis.糖尿病与肾癌风险之间的关联:系统评价与荟萃分析
Clin Diabetes. 2022 Summer;40(3):270-282. doi: 10.2337/cd21-0013.
5
American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.美国临床内分泌学会临床实践指南:制定糖尿病综合护理计划-2022 更新版。
Endocr Pract. 2022 Oct;28(10):923-1049. doi: 10.1016/j.eprac.2022.08.002. Epub 2022 Aug 11.
6
Long Non-Coding RNAs as Novel Biomarkers in the Clinical Management of Papillary Renal Cell Carcinoma Patients: A Promise or a Pledge?长链非编码 RNA 作为乳头状肾细胞癌患者临床管理的新型生物标志物:是承诺还是保证?
Cells. 2022 May 17;11(10):1658. doi: 10.3390/cells11101658.
7
Gender-Specific Metabolomics Approach to Kidney Cancer.针对肾癌的性别特异性代谢组学方法。
Metabolites. 2021 Nov 10;11(11):767. doi: 10.3390/metabo11110767.
8
Ampelopsin Inhibits Cell Viability and Metastasis in Renal Cell Carcinoma by Negatively Regulating the PI3K/AKT Signaling Pathway.白藜芦醇通过负向调节PI3K/AKT信号通路抑制肾细胞癌的细胞活力和转移。
Evid Based Complement Alternat Med. 2021 Nov 11;2021:4650566. doi: 10.1155/2021/4650566. eCollection 2021.
9
MicroRNA-501-3p inhibits the proliferation of kidney cancer cells by targeting WTAP.miR-501-3p 通过靶向 WTAP 抑制肾癌细胞的增殖。
Cancer Med. 2021 Oct;10(20):7222-7232. doi: 10.1002/cam4.4157. Epub 2021 Sep 30.
10
Sex and Gender Differences in Kidney Cancer: Clinical and Experimental Evidence.肾癌中的性别差异:临床与实验证据
Cancers (Basel). 2021 Sep 13;13(18):4588. doi: 10.3390/cancers13184588.

本文引用的文献

1
Circulating levels of obesity-related markers and risk of renal cell carcinoma in the PLCO cancer screening trial.PLCO癌症筛查试验中肥胖相关标志物的循环水平与肾细胞癌风险
Cancer Causes Control. 2017 Jul;28(7):801-807. doi: 10.1007/s10552-017-0901-3. Epub 2017 May 8.
2
Obesity and Kidney Cancer.肥胖与肾癌
Recent Results Cancer Res. 2016;208:81-93. doi: 10.1007/978-3-319-42542-9_5.
3
MicroRNA profiling in clear cell renal cell carcinoma tissues potentially links tumorigenesis and recurrence with obesity.透明细胞肾细胞癌组织中的微小RNA分析可能将肿瘤发生和复发与肥胖联系起来。
Br J Cancer. 2017 Jan 3;116(1):77-84. doi: 10.1038/bjc.2016.392. Epub 2016 Dec 1.
4
Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations.体重指数与转移性肾细胞癌:临床与生物学关联
J Clin Oncol. 2016 Oct 20;34(30):3655-3663. doi: 10.1200/JCO.2016.66.7311.
5
Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial.基于前列腺、肺、结肠直肠和卵巢癌筛查试验以及国家肺癌筛查试验参与者的肾细胞癌风险估计。
Urol Oncol. 2016 Apr;34(4):167.e9-16. doi: 10.1016/j.urolonc.2015.10.011. Epub 2015 Nov 18.
6
Association of hypertension and obesity with renal cell carcinoma risk: a report from the Shanghai Men's and Women's Health Studies.高血压和肥胖与肾细胞癌风险的关联:来自上海男性和女性健康研究的报告。
Cancer Causes Control. 2015 Aug;26(8):1173-80. doi: 10.1007/s10552-015-0611-7. Epub 2015 Jun 17.
7
Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinoma.高血压和血管紧张素系统抑制剂:对舒尼替尼治疗转移性肾细胞癌患者结局的影响。
Ann Oncol. 2015 Jun;26(6):1128-1133. doi: 10.1093/annonc/mdv147. Epub 2015 Mar 20.
8
Renin-angiotensin system (RAS) blockade attenuates growth and metastatic potential of renal cell carcinoma in mice.肾素-血管紧张素系统(RAS)阻断可减弱小鼠肾细胞癌的生长和转移潜能。
Urol Oncol. 2015 Sep;33(9):389.e1-7. doi: 10.1016/j.urolonc.2014.11.022. Epub 2015 Jan 13.
9
Incidental renal neoplasms: is there a need for routine screening? A Danish single-center epidemiological study.偶发性肾肿瘤:是否需要进行常规筛查?一项丹麦单中心流行病学研究。
APMIS. 2014 Aug;122(8):708-14. doi: 10.1111/apm.12282. Epub 2014 Jun 7.
10
Epidemiology and staging of renal cell carcinoma.肾细胞癌的流行病学与分期
Semin Intervent Radiol. 2014 Mar;31(1):3-8. doi: 10.1055/s-0033-1363837.